Ocugen, Inc. OCGN
Set alert
0.72 USD +0.02 +3.13%
At close
0.76 +0.04 +4.84%
Pre-market · Nov 3, 7:00 AM ET
0.7044 Day range 0.7476
0.691 52-week range 2.73
- YTD
- -46.32%
- 1 year
- -52.94%
- Open
- 0.72
- Prev close
- 0.7027
- Mkt cap
- 245.75M
- Vol
- 5.71M
- Avg vol
- 6.54M
- EPS
- -0.27
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.7044
- High
- 0.7476
- Forward P/E
- -2.85
- Beta
- 3.77
- Short ratio
- 14.01
- Inst. own
- 27.53%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 0.92278
- 200-d avg
- 1.30
- 1y target
- 6.25
3M chart
Signals (11)
| Name | Date | Ago |
|---|---|---|
| MACD: Buy Signal | Nov 2, 2026 | 21 hours ago |
| RSI: Oversold | Oct 30, 2026 | 3 days ago |
| MACD: Sell Signal | Oct 13, 2026 | 2 weeks ago |
| RSI: Oversold | Oct 13, 2026 | 2 weeks ago |
| MACD: Buy Signal | Sep 29, 2026 | 1 month ago |
| RSI: Oversold | Sep 15, 2026 | 1 month ago |
| RSI: Oversold | Sep 9, 2026 | 1 month ago |
| MACD: Sell Signal | Aug 31, 2026 | 2 months ago |
| SMA: Bullish | Aug 11, 2026 | 2 months ago |
| SMA: Bullish | Aug 11, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 7, 2026 | 2 months ago |
Analyst view
Consensus: none
Price target (mean) 6.25 +762.4% upside
Now 0.7247
- Target (low)
- 4.00
- Target (mean)
- 6.25
- Target (high)
- 8.00
Ratings (0m) 4 4 buy · 0 hold · 0 sell
- Strong buy2
- Buy2
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 4
- 1 month ago 4
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.05667 | -0.06 – -0.05 | -0.03 | -88.9% | 300.00K | -78.9% | 3 |
| Next quarter | -0.06 | -0.07 – -0.05 | -0.05 | -20.0% | 0 | -100.0% | 2 |
| Current year | -0.19 | -0.20 – -0.18 | -0.26 | +26.9% | 3.62M | -40.0% | 3 |
| Next year | -0.26667 | -0.32 – -0.20 | -0.19 | -40.4% | 0 | -100.0% | 3 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 18, 2024 | Chardan Capital | Maintained | Buy | Buy |
| Nov 14, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Nov 11, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Nov 8, 2024 | Chardan Capital | Maintained | Buy | Buy |
| Oct 23, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Oct 15, 2024 | Maxim Group | Initiated | — | Buy |
| May 15, 2024 | Chardan Capital | Maintained | Buy | Buy |
| May 15, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Apr 22, 2024 | Chardan Capital | Maintained | Buy | Buy |
| Apr 3, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Feb 22, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Jan 24, 2024 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Aug 31, 2023 | Cantor Fitzgerald | Maintained | Overweight | Overweight |
| Aug 23, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| May 8, 2023 | Chardan Capital | Maintained | — | Buy |
| Apr 17, 2023 | HC Wainwright & Co. | Reiterated | — | Buy |
| Apr 14, 2023 | Chardan Capital | Maintained | — | Buy |
| Mar 1, 2023 | Chardan Capital | Upgrade | Neutral | Buy |
| Mar 1, 2023 | Mizuho | Maintained | — | Buy |
| Mar 1, 2023 | HC Wainwright & Co. | Reiterated | — | Buy |
| Aug 23, 2022 | Mizuho | Initiated | — | Buy |
| Aug 15, 2022 | HC Wainwright & Co. | Maintained | — | Buy |
| Jun 2, 2022 | Cantor Fitzgerald | Initiated | — | Overweight |
| May 12, 2022 | HC Wainwright & Co. | Maintained | — | Buy |
| Feb 28, 2022 | HC Wainwright & Co. | Maintained | — | Buy |
| Jun 11, 2021 | Roth Capital | Downgrade | Buy | Neutral |
| Jun 11, 2021 | HC Wainwright & Co. | Maintained | — | Buy |
| May 7, 2021 | Cantor Fitzgerald | Downgrade | Overweight | Neutral |
| Mar 3, 2021 | Cantor Fitzgerald | Maintained | — | Overweight |
| Feb 9, 2021 | Chardan Capital | Downgrade | Buy | Neutral |